Publication number: 20250089551
Abstract: An organometallic compound represented by Formula 1: wherein M1 is a transition metal; Y1 to Y3 are each independently C or N; R4 is a substituted or unsubstituted C1-C60 alkyl group; ring CY2 to ring CY5 are each independently a C5-C60 carbocyclic group or a C1-C60 heterocyclic group; L1 is a single bond, O, S, Se, N(R61), B(R61), C(R61)(R62), or Si(R61)(R62); a1 is 1, 2, 3, 4, or 5; b10, b20, b30, b40, and b50 are each independently 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10; and the remaining substituent groups of Formula 1 are as provided herein.
Type:
Application
Filed:
September 4, 2024
Publication date:
March 13, 2025
Inventors:
Hwang Suk Kim, Sangmo Kim, Minsik Min, Hyejin Bae, Yeon Sook Chung, Hyesung Choi, Joon Heo, Hosuk Kang, Jong Soo Kim, Joonghyuk Kim, Youngmok Son, Yeonkyung Lee, Daun Jeong, Kyeongsik Ju
Publication number: 20250066347
Abstract: The present invention relates to: a substituted thiazolidinedione derivative compound having a novel structure acting as a sterol regulatory element-binding protein-1 (SREBP1) inhibitor, a hydrate thereof, or a pharmaceutically acceptable salt thereof; and a pharmaceutical composition for preventing or treating cancer, comprising same as an active ingredient.
Type:
Application
Filed:
December 19, 2022
Publication date:
February 27, 2025
Inventors:
Jun-Kyum KIM, Jia CHOI, Eun-Jung KIM, Cheol-Kyu PARK, Seok Won HAM, Min Gi PARK, Hyeon Ju JEONG, Sung Jin KIM, Kyungim MIN, Jong Min PARK, Jungwook CHIN, Sung Jin CHO, Jina KIM, Kyung Jin JUNG, Nayeon KIM, Suhui KIM, Sugyeong KWON, Su-Jeong LEE, Minseon JEONG, Hongchan AN, Jeong-Eun PARK, Dong-Hyun KIM, Ji-youn LIM, Ju-sik MIN, Ji Sun HWANG, Hyo-Jung CHOI, Hayoung HWANG, Oh-Bin KWON, Sungwoo LEE, Sang Bum KIM